|
HS Code |
744226 |
| Product Name | Boc-L-Glutamic Acid |
| Cas Number | 7556-11-4 |
| Molecular Formula | C10H17NO6 |
| Molecular Weight | 247.25 |
| Appearance | White to off-white powder |
| Melting Point | 113-117°C |
| Purity | ≥98% |
| Storage Temperature | 2-8°C |
| Solubility | Slightly soluble in water, soluble in organic solvents like methanol |
| Synonyms | N-Boc-L-glutamic acid; (S)-2-((tert-Butoxycarbonyl)amino)pentanedioic acid |
As an accredited Boc-L-Glutamic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Boc-L-Glutamic Acid, 100g, is packaged in a sealed, amber glass bottle with tamper-evident cap and labeled specifications. |
| Shipping | Boc-L-Glutamic Acid is shipped in sealed, chemical-resistant packaging to ensure stability and prevent contamination. It is transported under ambient conditions unless otherwise specified, with clear labeling and safety documentation included. Standard courier services are used, complying with relevant chemical transport regulations and guidelines for safe handling and delivery. |
| Storage | Boc-L-Glutamic Acid should be stored in a tightly sealed container, protected from moisture and light, at a temperature between 2-8°C (refrigerator conditions). Ensure proper labeling and avoid exposure to heat, acids, and bases. Store in a dry area away from incompatible substances, and handle in a well-ventilated space to maintain chemical integrity and prevent degradation. |
Applications of Boc-L-Glutamic Acid in Industrial ManufacturingBoc-L-Glutamic Acid plays a significant role as a protected amino acid intermediate across fine chemical and life science industry segments. As a direct manufacturer, we support diverse application fields by ensuring compliance with established chemical standards and delivering consistent quality for downstream synthesis and formulation. 1. Peptide Synthesis for Pharmaceutical IntermediatesIn pharmaceutical manufacturing, Boc-L-Glutamic Acid serves as a building block for protected peptide synthesis under solid or solution phase conditions. Research and production sites incorporate this intermediate to introduce side-chain protection, which enhances structural control throughout multi-step processes. Our material integrates during target-specific active pharmaceutical ingredient (API) projects, such as the assembly of complex peptide drug substances where proven processability and consistency influence both batch yields and regulatory submission integrity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Chemical Synthesis of Specialty PolymersManufacturers in the advanced materials sector incorporate this protected amino acid during the design of functionalized polyamides and biodegradable polymers. Through specific copolymerization routes, its protected groups offer reactive handles for post-polymer modification, enabling controlled functional group release under mild deprotection. Our chemical supports stable dispersion and modifies chain properties in downstream formulations used in targeted drug delivery vehicles and biomedical scaffolds. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Protected Amino Acid Source for Chiral Fine ChemicalsCustom synthesis plants for agrochemical, flavor, and fragrance sectors rely on Boc-L-Glutamic Acid in the preparation of chiral intermediates. Its protected form helps control racemization and side reactions during asymmetric syntheses. Technicians selectively deprotect the molecule under mild conditions when downstream conversion to target chiral compounds is required. Process engineers value the reproducibility and batch traceability of our raw material for scale-up of enantiomerically pure substances to support regulatory filings and pilot-to-commercial transfer. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Custom Oligonucleotide-Linked ConjugatesBoc-protected glutamic acid derivatives facilitate the coupling of amino acids to oligonucleotides and other bio-conjugates. Oligonucleotide CDMO (Contract Development and Manufacturing Organizations) select this material to introduce carboxyl activation and selective side chain modification when attaching peptides or imaging probes to nucleic acids. The protected acid group prevents non-specific activation, supporting complex conjugation workflows where purity and functional group integrity remain critical through process validation and batch release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-L-Glutamic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Decades of making amino acid derivatives have taught us that every stage in peptide production demands uncompromising consistency. With Boc-L-Glutamic Acid, manufactured in our own facilities, that consistency begins at the source and extends through every drum, every batch, every year. Research teams in demanding labs and production-scale pharmaceutical operations turn to this compound because they cannot afford surprises or second-guess the integrity of their starting materials.
Each lot of Boc-L-Glutamic Acid emerges from controlled environments where everything, from environmental conditions to process reagents, is monitored and verified by chemists who understand what can go wrong when starting materials fall short. This is not marketing—this is life in an industry where even a hint of contaminant can doom weeks of work downstream. Instead of chasing volume at the cost of quality, we pursue reproducibility and transparency. Our in-house team uses batch-specific HPLC, NMR, and mass spectrometry testing to make sure the product meets the criteria for research and commercial scale peptide synthesis.
Few raw materials see as much scrutiny as protected amino acids. Boc-L-Glutamic Acid (N-tert-Butoxycarbonyl-L-glutamic acid) plays a crucial role as a building block, especially for pharmaceutical, diagnostic, and biotech applications hinging on precise peptide sequences. We supply this compound with a purity of at least 98%, and most lots cross 99%, providing peace of mind not just for documentation but also for downstream yield and clean reactions. Each bag represents a culmination of process validation, not a shortcut. Impurity profiles for metal ions, enantiomeric purity, and residual solvents all remain documented and available for customers needing more than a certificate and a handshake.
Our standard offering features Boc-L-Glutamic Acid in white to off-white crystalline powder, with minimal moisture content, and less than 0.5% total impurities. In peptide coupling, moisture can ruin coupling efficiency or introduce side products; we keep strict water control in our drying and packaging areas. Experienced chemists running solid phase synthesis or manual protocols have come to trust that our batches flow straight into their workflows, without pre-treatment or extra purification steps.
We produce the material in GMP-aligned operations and maintain ISO certified processes. While many claim high purity, few routinely provide full supporting data on each lot, or back their products with traceable documentation down to the raw input stocks and auxiliary reagents. We make this commitment because we’ve dealt with the alternative: delayed campaigns, spurious side products, and a scramble to track down what went wrong after the fact.
A sizeable share of so-called “Boc-protected” glutamic acid in the global market is produced by smaller plants or contract mixers with partial control over their logistics. Many sources blend, repackage, or rebrand what they buy elsewhere, making traceability almost impossible. Such practices may shave a few points off the procurement budget, but they also risk introducing cross-contamination from other amino acids or related side products—these trace-level errors show up where visibility is lowest, but stakes are highest. We sidestep this by handling the process end-to-end.
Boc-L-Glutamic Acid is much more than an intermediary for our customers: it’s the backbone of correctly sequenced, structurally dependable peptides, especially for challenging core sequences where acid stability and side-chain protection matter. The Boc group provides temporary protection of the amino terminus, crucial for stepwise peptide elongation. Yet the L-glutamic acid backbone itself houses a reactive side chain carboxyl that can otherwise tangle up in unwanted condensation. Protect that side chain poorly, or accept lax standards, and peptides seldom turn out as intended. No screening instrument can compensate for a starting compound that’s not manufactured with these risks in mind.
In our interactions with peptide chemists, issues often trace back to variability in raw material lots—not process problems in their labs. Experienced users can spot negative reactions fast: fragmentary peptides at purification steps, unassignable HPLC peaks, or stubborn coupling reactions. Using Boc-L-Glutamic Acid from plants focused on low-impurity, single-source manufacturing solves many such headaches before they arise. As a manufacturer, we get direct feedback: our partners rely on the exact purity, and not having to compensate for erratic impurity profiles lets them streamline synthesis schedules and minimize troubleshooting.
Many labs using solid-phase synthesis require tight control over deprotection cycles, especially with Fmoc/Boc strategies. In multi-step protocols, a single out-of-spec Boc-amino acid can ruin the entire sequence, resulting in weeks of troubleshooting. Clients working with sensitive peptide API intermediates, diagnostic conjugates, or vaccine constructs value a robust supply chain that takes ownership of every step, from starting material sourcing to final QC. This trust forms only through repeated delivery of a product that performs whatever the scale.
We rely on closed-system reactors built for scale—a decision made after fielding complaints about handling from early, open-system processes prone to environmental exposure. Full automation on the charging and neutralization steps means that each aliquot receives the correct stoichiometry; mistakes at this stage guarantee a ripple effect down the line. After reaction, our purification trains prioritize removal of metal ions and colored byproducts, two frequent contaminants that escape cursory inspection. A laborious, multi-stage drying cycle helps reduce water content to near trace levels. These investments deliver batches that respond consistently in peptide syntheses, with less need for compensating measures in reaction condition optimization.
Laboratory staff constantly flag us when a lot’s crystal morphology or solubility falls outside historical ranges. Since we control the production and keep rigorous lot records, pinpointing and addressing deviations has become fast and painless. This transparency remains rare in the chemical supply sector, where repackagers and traders often lack direct oversight.
Smaller manufacturers or third-party middlemen rarely hold the resources for comprehensive lot testing. Some rely on supplier material safety data, with minimal in-house validation. We take a different approach: each finished batch is subject to at least triplicate purity testing, plus side-by-side analysis against previous lots. Everything we ship carries its own lot-specific results, allowing for backward traceability to raw input lot and production shift. When our customers report feedback, we connect their findings directly to production logs—this kind of dynamic feedback loop keeps us honest, and continuously sharpens product reliability.
Boc-L-Glutamic Acid’s uses stretch far beyond academic research. Diagnostic kit developers, peptide-based drug producers, and bioengineering firms all need materials that support sensitive synthetic operations at scale. Impurities—metal ion traces, residual solvents, or wrong stereochemistry—can compromise biological activity, introduce off-target metabolites, or force laborious purification downstream. Side reactions arise not just from “dirt” in the product, but subtle variances in particle size, crystallinity, or residual moisture. By investing in multi-stage air handling, redundant analytic cross-checks, and batch-wise documentation, we address these risks before they reach the end user.
When we compare our Boc-L-Glutamic Acid with lower-cost alternatives, a few differences stand out immediately. Moisture content affects how the compound integrates in fast automated synthesizers—excess water slows dissolution, introduces side reactions, or reduces coupling efficiency. We reject any batch that deviates from our tight moisture specs, because the downstream effects are costly and difficult to remediate after the peptide is built. Our material’s particle size and flow properties also receive periodic optimization: free-flowing powder pours smoothly without bridging or lag in feeders, reducing spillage and operator frustration during large-scale runs.
Long-standing relationships with academic labs and industry partners mean we get periodic field reports backed up by hard data. Several customers have reported marked improvements in peptide purity and process reliability after switching to our in-house material. The reduction in synthetic cycle failures, misassigned peaks, and sequence truncations rarely appears in a spreadsheet, but makes itself felt in cycle throughput, overtime hours reduced, and faster R&D progress. By keeping actual user feedback tied to our QC processes, we keep improving batch-to-batch reliability. This approach goes beyond compliance—it becomes the foundation for years of repeat business and mutual success.
While Boc-L-Glutamic Acid may look similar across suppliers, the devil lies in the details that are invisible until synthesis falls apart. Many third-party resellers repackage intermediates sourced from multiple upstream facilities, masking source variability behind uniform packaging. They may deliver “on spec” products by the numbers, but the internal variation between lots traps users in a cycle of troubleshooting. Drops in peptide yields, jumpy retention times on chromatography, or mysterious side-products often trace back to these hidden inconsistencies in the starting material.
We work upstream, where hands-on process control translates to dependability in the field. Instead of depending on brokers or joint venture partner stocks, our teams handle procurement, synthesis, workup, and analysis in house. Direct control means speed in resolving anomalies, restoring supply, or optimizing any step. We share full impurity profiles for each lot – not just summaries, but downloadable files upon request – so the connection between what leaves our facility and what happens at your bench remains direct.
Price per kilogram matters, but hidden costs often outrun headline savings: unplanned troubleshooting, unpurified intermediates, lost synthesis runs, and missed milestones. Our clients calculate the value of reliable Boc-L-Glutamic Acid by what it prevents as much as what it delivers. A single contaminated lot can stall a campaign or send teams searching for ghosts in their process. With a track record of reliable delivery and an open door for customer feedback, we lower project uncertainty and keep operations moving in real time.
Solvents and reagents in amino acid manufacture can impose a substantial environmental cost if left unchecked. We use closed-cycle solvent recovery and invest in waste minimization strategies, passing regular audits as part of our ISO certification. Not every supplier shoulders this burden; some export their environmental impact or remain opaque to buyers focused only on line-item costs. We make sustainability a feature, not a marketing banner, pooling years of engineering experience to minimize our chemical footprint and pass on cost reductions over the long haul. Customers who track life cycle inputs and sustainability ratings find our operation transparent from feedstock to final waste disposal.
We supply Boc-L-Glutamic Acid by the kilogram, drum, or larger project-run quantities, fulfilling contracts for research, pilot, and full-scale production needs. No batch leaves without complete QC clearance and lot documentation. Repeat buyers often request specific lot numbers based on past synthetic history, and our stock management system enables us to respond to these needs directly. This continuity in sourcing saves time, reduces retraining, and enables faster project ramp-up, especially for groups running high-throughput, multi-peptide workflows. Our dedicated technical support staff draw from direct access to production notes, original batch analytics, and customer communication logs, so troubleshooting and documentation requests are answered without delay.
Boc-L-Glutamic Acid serves as a core tool in modern peptide chemistry. Its quality, lot-to-lot consistency, and clear accountability define whether labs lose days to troubleshooting or move forward with productive synthesis. Decades of focused in-house manufacture, direct investment in analytic tools, and active customer engagement have formed the backbone of our approach. Users who have experienced unpredictable deliveries and low-grade materials find in our Boc-L-Glutamic Acid a chance to anchor their work on a product shaped by hands-on knowledge and evidence, not just sales copy. Professional integrity, scientific rigor, and practical feedback shape every batch we ship.